$DTIL 3 SEC Filings

Filed On	Filing
03 Aug 2026	Form 3: Gorsuch Cassandra Louise, Chief Scientific Officer Holds 16,028 shares of Common Stock
03 Aug 2026	Form 3: Burris Mei Zhang Lu, Chielf Accounting Officer Holds 5,115 shares of Common Stock
03 Aug 2026	Form 3: Tanna Naresh Haresh, Chief Financial Officer Holds 25,575 shares of Common Stock
09 Sep 2022	Form 3: Smith J. Jefferson, Chief Research Officer Holds 1,902,474 shares of Common Stock
27 Jun 2022	Form 3: Novartis Pharma Ag, 10% owner and 1 other Holds 12,407,440 shares of Common Stock
31 May 2022	Form 3: Brown Melinda, Director No securities owned
10 Nov 2021	Form 3: Wadsworth Samuel C., Director No securities owned
10 Nov 2021	Form 3: Pire Shari Lisa, Director No securities owned
19 Oct 2021	Form 3: Amoroso Michael, Director No securities owned
30 Apr 2021	Form 3: List Alan, Chief Medical Officer
14 Apr 2021	Form 3: Frankel Stanley, Director Holds 1,500 shares of Common Stock
06 Jan 2021	Form 3: Kelly John Alexander, Interim CFO Holds 15,800 shares of Common Stock
06 Jan 2021	Form 3: Barton Shane, VP & Corporate Controller
12 Mar 2020	Form 3: Germano Geno J, Director No securities owned
13 Nov 2019	Form 3: Buehler Kevin, Director No securities owned
08 Oct 2019	Form 3: Heery Christopher, Chief Medical Officer
14 Jun 2019	Form 3: Scimeca Dario, General Counsel No securities owned
27 Mar 2019	Form 3: Fmr Llc, 10% owner
27 Mar 2019	Form 3: Yao Tony Dung Ling, Director
27 Mar 2019	Form 3: Schinazi Raymond F, Director

Comments